The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials.

Sanford, D; Naidu, A; Alizadeh, N; Lazo-Langner, A

Sanford, D; Naidu, A; Alizadeh, N; Lazo-Langner, A.

Affiliation

Sanford D; Division of Hematology, Department of Medicine, London Health Sciences Centre, Western University, London, Ontario, Canada.

J Thromb Haemost ; 12(7): 1076-85, 2014 Jul.

Article in En | MEDLINE | ID: mdl-24796727

Subject(s)

Anticoagulants/therapeutic use; Blood Coagulation/drug effects; Heparin, Low-Molecular-Weight/therapeutic use; Neoplasms/drug therapy; Neoplasms/mortality; Venous Thrombosis/drug therapy; Aged; Female; Humans; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Treatment Outcome

Key words

cancer; hemorrhage; low molecular weight heparin; mortality; thrombosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Coagulation / Heparin, Low-Molecular-Weight / Venous Thrombosis / Anticoagulants / Neoplasms Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2014 Document type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google